Commentary
AlphaFold 2: Insights and Future Directions in Psychiatry
by Pascal Büttiker1, Simon Weissenberger1,2 Martin Anders1, Jiri Raboch1, George B. Stefano1 and Amira Boukherissa3,4
1Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, 120 00 Prague, Czech Republic
2Department of Psychology, University of New York in Prague, 120 00 Prague, Czech Republic
3Institute for Integrative Biology of the Cell (I2BC), UMR91918, CNRS, CEA, Paris-Saclay University, 91190 Gif-sur-Yvette, France
4Ecology Systematics Evolution (ESE), CNRS, AgroParisTech, Paris-Saclay University, 91400 Orsay, France
Cite as: Büttiker, P., Weissenberger, S., Anders, M., Raboch, J., Stefano, G.B., Boukherissa, A. (2025). AlphaFold 2: Insights and Future Directions in Psychiatry. THE MIND Bulletin on Mind-Body Medicine Research, 8, x-x. https://doi.org/10.61936/themind/202506305
Abstract
The intricate links between protein misfolding and psychiatric disorders have drawn increasing attention in recent years. Several published studies have highlighted the contributions of misfolded proteins to the pathophysiology of conditions that include schizophrenia, depression, Alzheimer’s disease, and prion diseases. Recent breakthroughs in computational approaches, exemplified by the artificial intelligence application AlphaFold 2, have enabled us to predict protein structures with remarkable precision, resulting in unprecedented insights into the molecular mechanisms driving psychiatric illnesses. However, challenges remain in the application of computational power and its accuracy, particularly given the unrealized potential of quantum computing (QC). This commentary examines current advances in protein-folding and its impact on psychiatric research, addresses several of the ongoing challenges, and discusses the future promise of QC for deepening our understanding and advancing the treatment of neuropsychiatric disorders.
Keywords: bioinformatics, AlphaFold2 (AF2), psychiatry, quantum computing (QC)
Proteins play critical roles in normal cellular functions and maintain specific structures that define their individual roles in biological processes. Misfolded proteins have been linked to several well-known psychiatric and neurodegenerative disorders. To address these concerns, we need to improve our collective understanding of both normal and dysregulated protein folding (Ciechanover & Kwon, 2015; Stefano, Büttiker, Weissenberger, Anders, et al., 2023). Traditional methods used to elucidate protein structure such as X-ray crystallography and nuclear magnetic resonance are time-consuming and costly. The AlphaFold 2 (AF2) artificial intelligence (AI) application developed by DeepMind (Alphabet) has revolutionized the prediction of highly accurate protein structures, thereby accelerating disease research (Borkakoti & Thornton, 2023; Büttiker et al., 2024; Jumper et al., 2021; McDonough, 2024). Despite these advantages, AF2 is not fully capable of capturing complex folding patterns and interactions within the dynamic environment of the brain. Emerging quantum computing (QC) methods offer potential solutions with faster calculations and advanced modeling capabilities (Stefano, 2024).
The Impact of AF2 on Psychiatric Research
AF2 has revolutionized computational biology and has provided accurate predictions of thousands of protein structures, making protein structure determinations more accessible to the medical research community (Varadi et al., 2022). Researchers have applied AF2 to elucidate the structures of proteins involved in neurotransmission, synaptic plasticity, and neuronal development, all critical pathways implicated in psychiatric conditions, notably schizophrenia and bipolar disorder (Büttiker et al., 2024; Stefano, Büttiker, Weissenberger, Esch, et al., 2023). We surmise that the new-found capacity to model proteins previously designated as difficult to characterize will help researchers identify novel therapeutic targets for these disorders. AF2-based strategies may also be used to identify targets that may respond to lifestyle modifications that can be addressed as a means to prevent a given psychiatric manifestation, e.g., targeting neurobiological systems associated with motivation and reward (Michaelsen & Esch, 2023). Despite these remarkable achievements, several limitations remain. While AF2 is highly effective at predicting static structures, structural analyses of complex dynamic protein-protein interactions and post-translational modifications remain challenging (Gomes et al., 2022). The AF2 program in its current form does not intrinsically account for the cellular environmental factors (pH, temperature, ion concentrations, and/or micro- and macro-environmental thermodynamics) that critically influence protein folding in the brain (Guo et al., 2022). Many proteins involved in neuronal signaling and that have been implicated in one or more psychiatric disorders undergo constant conformational changes. These changes are challenging to predict using current computational models.
Protein Folding Challenge
It is important to recognize that protein folding is a quantum mechanical process, involving atomic interactions that classical and current computing strategies cannot yet simulate efficiently. Based on fundamental units known as qubits and the capacity to leverage superposition and entanglement, QC can transform our approach to this problem by processing vast numbers of configurations simultaneously, thereby providing more accurate simulations of protein folding pathways (Stefano, 2023, 2024).
QC-based algorithms have the potential to model misfolded proteins linked to the pathogenesis of Alzheimer’s (e.g., amyloid-beta, tau), Parkinson’s (alpha-synuclein), and prion-associated diseases (Stefano, Büttiker, Weissenberger, Anders et al., 2023) and thus provide a more in-depth understanding of these disorders. Additionally, the use of QC-based algorithms may lead to improved insights into protein-drug complex stability, thereby supporting drug discovery efforts aimed at targets associated with psychiatric and neurodegenerative conditions.
Limitations of AF2-based QC
Although QC is clearly a promising advance, it remains in its infancy. Current quantum computers, including those from IBM and Google, are limited by the number of stable qubits and are affected by “quantum noise”; these factors reduce the reliability of the calculations performed and thus restrict the complexity of proteins that can be simulated (Shaib et al., 2023). Developing quantum algorithms that accurately predict protein folding also remains challenging and requires expertise in both quantum physics and molecular biology. Additionally, because quantum systems must be maintained at temperatures near absolute zero (-273.15 °C), the infrastructure needed to support these efforts is both costly and energy-intensive. While widespread use of QC in psychiatric research may be a decade or more away, current advances in error correction, qubit stability, and computational power suggest these limitations might be overcome in due course.
Future
We further surmise that advances in QC, when integrated with AI programs such as AF2, will greatly improve protein folding predictions, particularly those involved in dynamic interactions that are relevant to psychiatric disorders. Hybrid models that combine classical and QC may leverage the strengths of both frameworks and facilitate more rapid and accurate simulations of large protein complexes. Both current and future applications of AF2 will advance psychiatric research because of its accessibility and effective structural predictions. Enhanced machine learning techniques and the availability of advanced computational resources will lead to further improvements in predictions of dynamic interactions and post-translational protein modifications. Close collaboration between computational biologists, quantum physicists, and mental health experts will be the key to advancing this interdisciplinary field. Cross-disciplinary training and targeted research funding are vital to equip researchers with the skills needed to face these challenges. As these technologies converge, the ultimate goal will be to translate molecular insights into therapeutic strategies that will enhance the prevention, diagnosis, and treatment of psychiatric and neurodegenerative disorders.
Conclusion
The convergence of psychiatric research, AI-driven protein structure prediction, and QC offers the promise of advanced understanding and the development of novel targets and eventually treatments for a wide array of neuropsychiatric conditions. While AF2 provides accurate structural information and thus has expanded protein research, QC might be used to address current limitations in molecular simulation as the field matures. The integration of these two important advances may yield groundbreaking insights into the molecular basis of neurocognitive disorders and lead to new protein-targeted therapies. Importantly, QC has the potential to create genetic sequences directing associated gene expression, which will prove to be very useful in gene therapies.
Author contributions: Conceptualization, P.B.; investigation, P.B.; writing—original draft preparation, G.B.S., P.B.; writing—review and editing, S.W., M.A., J.R.; supervision, G.B.S.; project administration, G.B.S. All authors have read and agreed to the published version of the manuscript.
Acknowledgments: Pascal Büttiker is currently a PhD candidate and was awarded a stipend from the Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic.
Conflict of Interest: The authors declare that they have no competing interests.
Funding: This work was supported in part by Cooperatio Program, research area Neuroscience, and by the project MH CZ – DRO VFN64165.
References
Borkakoti, N., & Thornton, J. M. (2023). AlphaFold2 protein structure prediction: Implications for drug discovery. Curr Opin Struct Biol, 78, 102526. https://doi.org/10.1016/j.sbi.2022.102526
Buttiker, P., Boukherissa, A., Weissenberger, S., Ptacek, R., Anders, M., Raboch, J., & Stefano, G. B. (2024). Cognitive Impact of Neurotropic Pathogens: Investigating Molecular Mimicry through Computational Methods. Cell Mol Neurobiol, 44(1), 72. https://doi.org/10.1007/s10571-024-01509-x
Ciechanover, A., & Kwon, Y. T. (2015). Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med, 47(3), e147. https://doi.org/10.1038/emm.2014.117
Gomes, P., Gomes, D. E. B., & Bernardi, R. C. (2022). Protein structure prediction in the era of AI: Challenges and limitations when applying to in silico force spectroscopy. Front Bioinform, 2, 983306. https://doi.org/10.3389/fbinf.2022.983306
Guo, H. B., Perminov, A., Bekele, S., Kedziora, G., Farajollahi, S., Varaljay, V., Hinkle, K., Molinero, V., Meister, K., Hung, C., Dennis, P., Kelley-Loughnane, N., & Berry, R. (2022). AlphaFold2 models indicate that protein sequence determines both structure and dynamics. Sci Rep, 12(1), 10696. https://doi.org/10.1038/s41598-022-14382-9
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Zidek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., . . . Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583-589. https://doi.org/10.1038/s41586-021-03819-2
McDonough, B. M. (2024, October 15). Did AI solve the Protein-Folding problem? Harvard Medicine Magazine. https://magazine.hms.harvard.edu/articles/did-ai-solve-protein-folding-problem?utm_source=AcousticMailing&utm_medium=email&utm_campaign=HMNews_102924%20(1)&utm_content=HMNews_1029_2024
Michaelsen, M. M., & Esch, T. (2023). Understanding health behavior change by motivation and reward mechanisms: a review of the literature. Front Behav Neurosci, 17, 1151918. https://doi.org/10.3389/fnbeh.2023.1151918
Shaib, A., Naim, M. H., Fouda, M. E., Kanj, R., & Kurdahi, F. (2023). Efficient noise mitigation technique for quantum computing. Sci Rep, 13(1), 3912. https://doi.org/10.1038/s41598-023-30510-5
Stefano, G. B. (2023). Artificial Intelligence as a Tool for the Diagnosis and Treatment of Neurodegenerative Diseases. Brain Sci, 13(6). https://doi.org/10.3390/brainsci13060938
Stefano, G. B. (2024). Quantum Computing and the Future of Neurodegeneration and Mental Health Research. Brain Sciences, 14, 93-95. https://doi.org/org/10.3390/brainsci14010093
Stefano, G. B., Buttiker, P., Weissenberger, S., Anders, M., Raboch, J., Ptacek, R., & Kream, R. M. (2023). Potential Prion Involvement in Long COVID-19 Neuropathology, Including Behavior. Cell Mol Neurobiol, 43(6), 2621-2626. https://doi.org/10.1007/s10571-023-01342-8
Stefano, G. B., Buttiker, P., Weissenberger, S., Esch, T., Michaelsen, M. M., Anders, M., Raboch, J., & Ptacek, R. (2023). Artificial Intelligence: Deciphering the Links between Psychiatric Disorders and Neurodegenerative Disease. Brain Sci, 13(7). https://doi.org/10.3390/brainsci13071055
Varadi, M., Anyango, S., Deshpande, M., Nair, S., Natassia, C., Yordanova, G., Yuan, D., Stroe, O., Wood, G., Laydon, A., Zidek, A., Green, T., Tunyasuvunakool, K., Petersen, S., Jumper, J., Clancy, E., Green, R., Vora, A., Lutfi, M., . . . Velankar, S. (2022). AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res, 50(D1), D439-D444. https://doi.org/10.1093/nar/gkab1061